Related Articles for PubMed (Select 18577240)

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.

Li W, Cagle PT, Botero RC, Liang JJ, Zhang Z, Tan D.

J Exp Clin Cancer Res. 2008 May 15;27:2.

PMID: 18577240 [PubMed - indexed for MEDLINE]

Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.

Guzman G, Wu SJ, Kajdacsy-Balla A, Cotler SJ.

Appl Immunohistochem Mol Morphol. 2006 Dec;14(4):411-6.

PMID: 17122637 [PubMed - indexed for MEDLINE]

Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.

Lin A, Weiser MR, Klimstra DS, Paty PB, Tang LH, Al-Ahmadie H, Hoo Park S, Guillem JG, Temple L, Wong WD, Gerald WL, Shia J.

Hum Pathol. 2007 Jun;38(6):850-6. Epub 2007 Apr 18.

PMID: 17442371 [PubMed - indexed for MEDLINE]

Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.

Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH.

Prostate. 2005 Jun 1;63(4):341-6.

PMID: 15602744 [PubMed - indexed for MEDLINE]

Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.

Nassar A, Amin MB, Sexton DG, Cohen C.

Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):252-5.

PMID: 16082251 [PubMed - indexed for MEDLINE]

Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.

Herawi M, Epstein JI.

Am J Surg Pathol. 2007 Jun;31(6):889-94.

PMID: 17527076 [PubMed - indexed for MEDLINE]

Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma.

Li W, Tan D, Zhang Z, Liang JJ, Brown RE.

Oncol Rep. 2008 Oct;20(4):713-9.

PMID: 18813808 [PubMed - indexed for MEDLINE]

A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.

Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG.

Cancer Detect Prev. 2003;27(6):422-6.

PMID: 14642549 [PubMed - indexed for MEDLINE]

Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.

Leav I, McNeal JE, Ho SM, Jiang Z.

Hum Pathol. 2003 Mar;34(3):228-33.

PMID: 12673556 [PubMed - indexed for MEDLINE]

10:

Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation.

Shi X, Gong E, Wu X.

Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):175-80.

PMID: 17525630 [PubMed - indexed for MEDLINE]

11:

Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.

Lee WA.

Oncology. 2006;71(3-4):246-50. Epub 2007 Jul 23.

PMID: 17652945 [PubMed - indexed for MEDLINE]

12:

Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.

Shilo K, Dracheva T, Mani H, Fukuoka J, Sesterhenn IA, Chu WS, Shih JH, Jen J, Travis WD, Franks TJ.

Arch Pathol Lab Med. 2007 Oct;131(10):1555-60.

PMID: 17922592 [PubMed - indexed for MEDLINE]

13:

Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.

Skinnider BF, Oliva E, Young RH, Amin MB.

Am J Surg Pathol. 2004 Jun;28(6):701-5.

PMID: 15166661 [PubMed - indexed for MEDLINE]

14:

Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.

Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG.

Hum Pathol. 2003 Aug;34(8):792-6.

PMID: 14506641 [PubMed - indexed for MEDLINE]

15:

Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Stewart J, Fleshner N, Cole H, Sweet J.

J Clin Pathol. 2007 Jul;60(7):773-80. Epub 2006 Aug 17.

PMID: 16916997 [PubMed - indexed for MEDLINE]

16:

Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.

Hameed O, Sublett J, Humphrey PA.

Am J Surg Pathol. 2005 May;29(5):579-87.

PMID: 15832080 [PubMed - indexed for MEDLINE]

17:

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Jiang Z, Woda BA, Wu CL, Yang XJ.

Am J Clin Pathol. 2004 Aug;122(2):275-89. Review.

PMID: 15323145 [PubMed - indexed for MEDLINE]

18:

Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.

Zhou M, Jiang Z, Epstein JI.

Am J Surg Pathol. 2003 Jun;27(6):772-8.

PMID: 12766580 [PubMed - indexed for MEDLINE]

19:

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID: 17134736 [PubMed - indexed for MEDLINE]

20:

Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.

Vanguri VK, Woda BA, Jiang Z.

Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):365-8.

PMID: 16932031 [PubMed - indexed for MEDLINE]

Recent Activity